URMC / Labs / Chu Lab / Publications

Recent Publications

1. Bruno JE
2. Herne CA
3. Baran AM
4. VanDerMeid KR
5. Barr PM
6. Williams AR
7. Quataert SA
8. Mosmann TR
9. Zent CS
10. Chu CC
Treatment of Relapsed/Refractory CLL Patients With PI3Kδ Inhibitor and Anti-CD20 Antibody Rapidly Decreases Tumor Burden but Could Induce Resistance.; American journal of hematology. 2025 Jan 02.
1. Van Wagoner CM
2. Rivera-Escalera F
3. Jaimes-Delgadillo NC
4. Chu CC
5. Zent CS
6. Elliott MR
Antibody-mediated phagocytosis in cancer immunotherapy.; Immunological reviews. 2023 Aug 21.
1. Brady MT
2. Laniewski N
3. Strawderman M
4. Chu CC
5. Kanagaiah P
6. Sangster MY
7. Topham DJ
8. Friedberg JW
9. Zent CS
Long-term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial Bruton tyrosine kinase inhibitors therapy for chronic lymphocytic leukemia or lymphoplasmacytic lymphoma.; American journal of hematology. 2023 Jul 23.
1. Moore JE
2. Bloom PC
3. Chu CC
4. Bruno JE
5. Herne CA
6. Baran AM
7. Quataert SA
8. Mosmann TR
9. Taylor RP
10. Wallace DS
11. Elliott MR
12. Barr PM
13. Zent CS
Rituximab induced cytokine release with high serum IP-10 (CXCL10) concentrations is associated with infusion reactions.; Leukemia research; Vol 129, pp. 107072. 2023 Mar 29.
1. Pinney JJ
2. Blick-Nitko SK
3. Baran AM
4. Peterson DR
5. Whitehead HE
6. Izumi R
7. Munugalavadla V
8. Van DerMeid KR
9. Barr PM
10. Zent CS
11. Elliott MR
12. Chu CC
The highly selective Bruton tyrosine kinase inhibitor acalabrutinib leaves macrophage phagocytosis intact.; Haematologica. 2022 Feb 17.
1. Rajendran NK
2. Liu W
3. Chu CC
4. Cahill PA
5. Redmond EM
Moderate dose alcohol protects against serum amyloid protein A1-induced endothelial dysfunction via both notch-dependent and notch-independent pathways.; Alcoholism, clinical and experimental research. 2021 Sep 29.
1. Zent CS
2. Pinney JJ
3. Chu CC
4. Elliott MR
Complement Activation in the Treatment of B-Cell Malignancies.; Antibodies (Basel, Switzerland); Vol 9(4). 2020 Dec 01.
1. Zent CS
2. Brady MT
3. Delage C
4. Strawderman M
5. Laniewski N
6. Contant PN
7. Kanagaiah P
8. Sangster MY
9. Barr PM
10. Chu CC
11. Topham DJ
12. Friedberg JW
Short term results of vaccination with adjuvanted recombinant varicella zoster glycoprotein E during initial BTK inhibitor therapy for CLL or lymphoplasmacytic lymphoma.; Leukemia. 2020 Oct 30.
1. Pinney JJ
2. Rivera-Escalera F
3. Chu CC
4. Whitehead HE
5. VanDerMeid K
6. Nelson AM
7. Barbeau MC
8. Zent CS
9. Elliott MR
Macrophage hypophagia as a mechanism of innate immune exhaustion in mAb-induced cell clearance.; Blood. 2020 Jun 17.
1. Chu CC
2. Pinney JJ
3. Whitehead HE
4. Rivera-Escalera F
5. VanDerMeid KR
6. Zent CS
7. Elliott MR
High-resolution quantitation of discrete phagocytic events by live cell time-lapse high-content microscopy imaging.; Journal of cell science. 2020 Jan 31.
1. Chu CC
2. Pinney JJ
3. Whitehead HE
4. Rivera-Escalera F
5. VanDerMeid KR
6. Zent CS
7. Elliott MR
High-resolution quantitation of discrete phagocytic events by live cell time-lapse high-content microscopy imaging.; Journal of cell science. 2020 Jan 01.
1. VanDerMeid KR
2. Elliott MR
3. Baran AM
4. Barr PM
5. Chu CC
6. Zent CS
Cellular Cytotoxicity of Next Generation CD20 Monoclonal Antibodies.; Cancer immunology research. 2018 Aug 08.
1. Baliakas P
2. Mattsson M
3. Hadzidimitriou A
4. Minga E
5. Agathangelidis A
6. Sutton LA
7. Scarfo L
8. Davis Z
9. Yan XJ
10. Plevova K
11. Sandberg Y
12. Vojdeman FJ
13. Tzenou T
14. Chu CC
15. Veronese S
16. Mansouri L
17. Smedby KE
18. Giudicelli V
19. Nguyen-Khac F
20. Panagiotidis P
21. Juliusson G
22. Anagnostopoulos A
23. Lefranc MP
24. Trentin L
25. Catherwood M
26. Montillo M
27. Niemann CU
28. Langerak AW
29. Pospisilova S
30. Stavroyianni N
31. Chiorazzi N
32. Oscier D
33. Jelinek DF
34. Shanafelt T
35. Darzentas N
36. Belessi C
37. Davi F
38. Ghia P
39. Rosenquist R
40. Stamatopoulos K
No improvement in long-term survival over time for chronic lymphocytic leukemia patients in stereotyped subsets #1 and #2 treated with chemo(immuno)therapy.; Haematologica. 2017 Dec 21.
1. Xochelli A
2. Baliakas P
3. Kavakiotis I
4. Agathangelidis A
5. Sutton LA
6. Minga E
7. Ntoufa S
8. Tausch E
9. Yan XJ
10. Shanafelt T
11. Plevova K
12. Boudjogra M
13. Rossi D
14. Davis Z
15. Navarro A
16. Sandberg Y
17. Vojdeman FJ
18. Scarfo L
19. Stavroyianni N
20. Sudarikov A
21. Veronese S
22. Tzenou T
23. Karan-Djurasevic T
24. Catherwood M
25. Kienle D
26. Chatzouli M
27. Facco M
28. Bahlo J
29. Pott C
30. Pedersen LB
31. Mansouri L
32. Smedby KE
33. Chu CC
34. Giudicelli V
35. Lefranc MP
36. Panagiotidis P
37. Juliusson G
38. Anagnostopoulos A
39. Vlahavas I
40. Antic D
41. Trentin L
42. Montillo M
43. Niemann C
44. Döhner H
45. Langerak AW
46. Pospisilova S
47. Hallek M
48. Campo E
49. Chiorazzi N
50. Maglaveras N
51. Oscier D
52. Gaidano G
53. Jelinek DF
54. Stilgenbauer S
55. Chouvarda I
56. Darzentas N
57. Belessi C
58. Davi F
59. Hadzidimitriou A
60. Rosenquist R
61. Ghia P
62. Stamatopoulos K
Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.; Clinical cancer research : an official journal of the American Association for Cancer Research; Vol 23(17). 2017 Sep 01.
1. Catera R
2. Liu Y
3. Gao C
4. Yan XJ
5. Magli A
6. Allen SL
7. Kolitz JE
8. Rai KR
9. Chu CC
10. Feizi T
11. Stamatopoulos K
12. Chiorazzi N
Binding of CLL subset 4 B-cell receptor immunoglobulins to viable human memory B lymphocytes requires a distinctive IGKV somatic mutation.; Molecular medicine (Cambridge, Mass.); Vol 23. 2017 Jan 12.
1. Yuan C
2. Chu CC
3. Yan XJ
4. Bagnara D
5. Chiorazzi N
6. MacCarthy T
The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.; PloS one; Vol 12(1). 2017.
1. Hatzi K
2. Catera R
3. Moreno Atanasio C
4. Fischetti VA
5. Allen SL
6. Kolitz JE
7. Rai KR
8. Chu CC
9. Chiorazzi N
Chronic lymphocytic leukemia immunoglobulins display bacterial reactivity that converges and diverges from auto-/poly-reactivity and IGHV mutation status.; Clinical immunology (Orlando, Fla.); Vol 172. 2016 Nov.
1. Patten PE
2. Ferrer G
3. Chen SS
4. Simone R
5. Marsilio S
6. Yan XJ
7. Gitto Z
8. Yuan C
9. Kolitz JE
10. Barrientos J
11. Allen SL
12. Rai KR
13. MacCarthy T
14. Chu CC
15. Chiorazzi N
Chronic lymphocytic leukemia cells diversify and differentiate in vivo via a nonclassical Th1-dependent, Bcl-6-deficient process.; JCI insight; Vol 1(4). 2016 Apr 07.
1. Cui X
2. Zhang L
3. Magli AR
4. Catera R
5. Yan XJ
6. Griffin DO
7. Rothstein TL
8. Barrientos J
9. Kolitz JE
10. Allen SL
11. Rai KR
12. Chiorazzi N
13. Chu CC
Cytoplasmic myosin-exposed apoptotic cells appear with caspase-3 activation and enhance CLL cell viability.; Leukemia; Vol 30(1). 2016 Jan.
1. Mongini PK
2. Gupta R
3. Boyle E
4. Nieto J
5. Lee H
6. Stein J
7. Bandovic J
8. Stankovic T
9. Barrientos J
10. Kolitz JE
11. Allen SL
12. Rai K
13. Chu CC
14. Chiorazzi N
TLR-9 and IL-15 Synergy Promotes the In Vitro Clonal Expansion of Chronic Lymphocytic Leukemia B Cells.; Journal of immunology (Baltimore, Md. : 1950); Vol 195(3). 2015 Aug 01.
1. Gounari M
2. Ntoufa S
3. Apollonio B
4. Papakonstantinou N
5. Ponzoni M
6. Chu CC
7. Rossi D
8. Gaidano G
9. Chiorazzi N
10. Stamatopoulos K
11. Ghia P
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8.; Blood; Vol 125(23). 2015 Jun 04.
1. Liu L
2. Yu H
3. Huang X
4. Tan H
5. Li S
6. Luo Y
7. Zhang L
8. Jiang S
9. Jia H
10. Xiong Y
11. Zhang R
12. Huang Y
13. Chu CC
14. Tian W
A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity.; BMC cancer; Vol 15. 2015 Mar 25.
1. Baliakas P
2. Agathangelidis A
3. Hadzidimitriou A
4. Sutton LA
5. Minga E
6. Tsanousa A
7. Scarfò L
8. Davis Z
9. Yan XJ
10. Shanafelt T
11. Plevova K
12. Sandberg Y
13. Vojdeman FJ
14. Boudjogra M
15. Tzenou T
16. Chatzouli M
17. Chu CC
18. Veronese S
19. Gardiner A
20. Mansouri L
21. Smedby KE
22. Pedersen LB
23. Moreno D
24. Van Lom K
25. Giudicelli V
26. Francova HS
27. Nguyen-Khac F
28. Panagiotidis P
29. Juliusson G
30. Angelis L
31. Anagnostopoulos A
32. Lefranc MP
33. Facco M
34. Trentin L
35. Catherwood M
36. Montillo M
37. Geisler CH
38. Langerak AW
39. Pospisilova S
40. Chiorazzi N
41. Oscier D
42. Jelinek DF
43. Darzentas N
44. Belessi C
45. Davi F
46. Ghia P
47. Rosenquist R
48. Stamatopoulos K
Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.; Blood; Vol 125(5). 2015 Jan 29.
1. Baliakas P
2. Hadzidimitriou A
3. Sutton LA
4. Minga E
5. Agathangelidis A
6. Nichelatti M
7. Tsanousa A
8. Scarfò L
9. Davis Z
10. Yan XJ
11. Shanafelt T
12. Plevova K
13. Sandberg Y
14. Vojdeman FJ
15. Boudjogra M
16. Tzenou T
17. Chatzouli M
18. Chu CC
19. Veronese S
20. Gardiner A
21. Mansouri L
22. Smedby KE
23. Pedersen LB
24. van Lom K
25. Giudicelli V
26. Francova HS
27. Nguyen-Khac F
28. Panagiotidis P
29. Juliusson G
30. Angelis L
31. Anagnostopoulos A
32. Lefranc MP
33. Facco M
34. Trentin L
35. Catherwood M
36. Montillo M
37. Geisler CH
38. Langerak AW
39. Pospisilova S
40. Chiorazzi N
41. Oscier D
42. Jelinek DF
43. Darzentas N
44. Belessi C
45. Davi F
46. Rosenquist R
47. Ghia P
48. Stamatopoulos K
Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.; The Lancet. Haematology; Vol 1(2). 2014 Nov.
1. Hwang KK
2. Trama AM
3. Kozink DM
4. Chen X
5. Wiehe K
6. Cooper AJ
7. Xia SM
8. Wang M
9. Marshall DJ
10. Whitesides J
11. Alam M
12. Tomaras GD
13. Allen SL
14. Rai KR
15. McKeating J
16. Catera R
17. Yan XJ
18. Chu CC
19. Kelsoe G
20. Liao HX
21. Chiorazzi N
22. Haynes BF
IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.; PloS one; Vol 9(3). 2014.
1. Cesano A
2. Perbellini O
3. Evensen E
4. Chu CC
5. Cioffi F
6. Ptacek J
7. Damle RN
8. Chignola R
9. Cordeiro J
10. Yan XJ
11. Hawtin RE
12. Nichele I
13. Ware JR
14. Cavallini C
15. Lovato O
16. Zanotti R
17. Rai KR
18. Chiorazzi N
19. Pizzolo G
20. Scupoli MT
Association between B-cell receptor responsiveness and disease progression in B-cell chronic lymphocytic leukemia: results from single cell network profiling studies.; Haematologica; Vol 98(4). 2013 Apr.
1. Patten PE
2. Chu CC
3. Albesiano E
4. Damle RN
5. Yan XJ
6. Kim D
7. Zhang L
8. Magli AR
9. Barrientos J
10. Kolitz JE
11. Allen SL
12. Rai KR
13. Roa S
14. Mongini PK
15. MacCarthy T
16. Scharff MD
17. Chiorazzi N
IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions.; Blood; Vol 120(24). 2012 Dec 06.
1. Agathangelidis A
2. Darzentas N
3. Hadzidimitriou A
4. Brochet X
5. Murray F
6. Yan XJ
7. Davis Z
8. van Gastel-Mol EJ
9. Tresoldi C
10. Chu CC
11. Cahill N
12. Giudicelli V
13. Tichy B
14. Pedersen LB
15. Foroni L
16. Bonello L
17. Janus A
18. Smedby K
19. Anagnostopoulos A
20. Merle-Beral H
21. Laoutaris N
22. Juliusson G
23. di Celle PF
24. Pospisilova S
25. Jurlander J
26. Geisler C
27. Tsaftaris A
28. Lefranc MP
29. Langerak AW
30. Oscier DG
31. Chiorazzi N
32. Belessi C
33. Davi F
34. Rosenquist R
35. Ghia P
36. Stamatopoulos K
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies.; Blood; Vol 119(19). 2012 May 10.
1. Hwang KK
2. Chen X
3. Kozink DM
4. Gustilo M
5. Marshall DJ
6. Whitesides JF
7. Liao HX
8. Catera R
9. Chu CC
10. Yan XJ
11. Luftig MA
12. Haynes BF
13. Chiorazzi N
Enhanced outgrowth of EBV-transformed chronic lymphocytic leukemia B cells mediated by coculture with macrophage feeder cells.; Blood; Vol 119(7). 2012 Feb 16.
1. Ghiotto F
2. Marcatili P
3. Tenca C
4. Calevo MG
5. Yan XJ
6. Albesiano E
7. Bagnara D
8. Colombo M
9. Cutrona G
10. Chu CC
11. Morabito F
12. Bruno S
13. Ferrarini M
14. Tramontano A
15. Fais F
16. Chiorazzi N
Mutation pattern of paired immunoglobulin heavy and light variable domains in chronic lymphocytic leukemia B cells.; Molecular medicine (Cambridge, Mass.); Vol 17(11-12). 2011.
1. Chu CC
2. Zhang L
3. Dhayalan A
4. Agagnina BM
5. Magli AR
6. Fraher G
7. Didier S
8. Johnson LP
9. Kennedy WJ
10. Damle RN
11. Yan XJ
12. Patten PE
13. Teichberg S
14. Koduru P
15. Kolitz JE
16. Allen SL
17. Rai KR
18. Chiorazzi N
Torque teno virus 10 isolated by genome amplification techniques from a patient with concomitant chronic lymphocytic leukemia and polycythemia vera.; Molecular medicine (Cambridge, Mass.); Vol 17(11-12). 2011.
1. Chu CC
2. Catera R
3. Zhang L
4. Didier S
5. Agagnina BM
6. Damle RN
7. Kaufman MS
8. Kolitz JE
9. Allen SL
10. Rai KR
11. Chiorazzi N
Many chronic lymphocytic leukemia antibodies recognize apoptotic cells with exposed nonmuscle myosin heavy chain IIA: implications for patient outcome and cell of origin.; Blood; Vol 115(19). 2010 May 13.
1. Seiler T
2. Woelfle M
3. Yancopoulos S
4. Catera R
5. Li W
6. Hatzi K
7. Moreno C
8. Torres M
9. Paul S
10. Dohner H
11. Stilgenbauer S
12. Kaufman MS
13. Kolitz JE
14. Allen SL
15. Rai KR
16. Chu CC
17. Chiorazzi N
Characterization of structurally defined epitopes recognized by monoclonal antibodies produced by chronic lymphocytic leukemia B cells.; Blood; Vol 114(17). 2009 Oct 22.
1. Chu CC
2. Catera R
3. Hatzi K
4. Yan XJ
5. Zhang L
6. Wang XB
7. Fales HM
8. Allen SL
9. Kolitz JE
10. Rai KR
11. Chiorazzi N
Chronic lymphocytic leukemia antibodies with a common stereotypic rearrangement recognize nonmuscle myosin heavy chain IIA.; Blood; Vol 112(13). 2008 Dec 15.
1. Catera R
2. Silverman GJ
3. Hatzi K
4. Seiler T
5. Didier S
6. Zhang L
7. Hervé M
8. Meffre E
9. Oscier DG
10. Vlassara H
11. Scofield RH
12. Chen Y
13. Allen SL
14. Kolitz J
15. Rai KR
16. Chu CC
17. Chiorazzi N
Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.; Molecular medicine (Cambridge, Mass.); Vol 14(11-12). 2008 Nov.
1. Benoff S
2. Chu CC
3. Marmar JL
4. Sokol RZ
5. Goodwin LO
6. Hurley IR
Voltage-dependent calcium channels in mammalian spermatozoa revisited.; Frontiers in bioscience : a journal and virtual library; Vol 12. 2007 Jan 01.
1. Guzowski D
2. Chandrasekaran A
3. Gawel C
4. Palma J
5. Koenig J
6. Wang XP
7. Dosik M
8. Kaplan M
9. Chu CC
10. Chavan S
11. Furie R
12. Albesiano E
13. Chiorazzi N
14. Goodwin L
Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography.; Journal of biomolecular techniques : JBT; Vol 16(2). 2005 Jun.
1. Desai A
2. Victor-Vega C
3. Gadangi S
4. Montesinos MC
5. Chu CC
6. Cronstein BN
Adenosine A2A receptor stimulation increases angiogenesis by down-regulating production of the antiangiogenic matrix protein thrombospondin 1.; Molecular pharmacology; Vol 67(5). 2005 May.
1. Mason JM
2. Naidu MD
3. Barcia M
4. Porti D
5. Chavan SS
6. Chu CC
IL-4-induced gene-1 is a leukocyte L-amino acid oxidase with an unusual acidic pH preference and lysosomal localization.; Journal of immunology (Baltimore, Md. : 1950); Vol 173(7). 2004 Oct 01.
1. Miura Y
2. Chu CC
3. Dines DM
4. Asnis SE
5. Furie RA
6. Chiorazzi N
Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion.; Molecular medicine (Cambridge, Mass.); Vol 9(5-8). 2003 May.
1. Tian W
2. Chua K
3. Strober W
4. Chu CC
ILG1 : a new integrase-like gene that is a marker of bacterial contamination by the laboratory Escherichia coli strain TOP10F'.; Molecular medicine (Cambridge, Mass.); Vol 8(7). 2002 Jul.
1. Chavan SS
2. Tian W
3. Hsueh K
4. Jawaheer D
5. Gregersen PK
6. Chu CC
Characterization of the human homolog of the IL-4 induced gene-1 (Fig1).; Biochimica et biophysica acta; Vol 1576(1-2). 2002 Jun 07.
1. Hirose N
2. Williams R
3. Alberts AR
4. Furie RA
5. Chartash EK
6. Jain RI
7. Sison C
8. Lahita RG
9. Merrill JT
10. Cucurull E
11. Gharavi AE
12. Sammaritano LR
13. Salmon JE
14. Hashimoto S
15. Sawada T
16. Chu CC
17. Gregersen PK
18. Chiorazzi N
A role for the polymorphism at position 247 of the beta2-glycoprotein I gene in the generation of anti-beta2-glycoprotein I antibodies in the antiphospholipid syndrome.; Arthritis and rheumatism; Vol 42(8). 1999 Aug.
1. Chu CC
2. Paul WE
Expressed genes in interleukin-4 treated B cells identified by cDNA representational difference analysis.; Molecular immunology; Vol 35(8). 1998 Jun.
1. Chu CC
2. Paul WE
Fig1, an interleukin 4-induced mouse B cell gene isolated by cDNA representational difference analysis.; Proceedings of the National Academy of Sciences of the United States of America; Vol 94(6). 1997 Mar 18.
1. Shimoda K
2. van Deursen J
3. Sangster MY
4. Sarawar SR
5. Carson RT
6. Tripp RA
7. Chu C
8. Quelle FW
9. Nosaka T
10. Vignali DA
11. Doherty PC
12. Grosveld G
13. Paul WE
14. Ihle JN
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene.; Nature; Vol 380(6575). 1996 Apr 18.
1. Nakanishi K
2. Yoshimoto T
3. Chu CC
4. Matsumoto H
5. Hase K
6. Nagai N
7. Tanaka T
8. Miyasaka M
9. Paul WE
10. Shinka S
IL-2 inhibits IL-4-dependent IgE and IgG1 production in vitro and in vivo.; International immunology; Vol 7(2). 1995 Feb.
1. Clark AJ
2. Satin L
3. Chu CC
Transcription of the Escherichia coli recE gene from a promoter in Tn5 and IS50.; Journal of bacteriology; Vol 176(22). 1994 Nov.
1. Clark AJ
2. Sharma V
3. Brenowitz S
4. Chu CC
5. Sandler S
6. Satin L
7. Templin A
8. Berger I
9. Cohen A
Genetic and molecular analyses of the C-terminal region of the recE gene from the Rac prophage of Escherichia coli K-12 reveal the recT gene.; Journal of bacteriology; Vol 175(23). 1993 Dec.
1. Mandler R
2. Chu CC
3. Paul WE
4. Max EE
5. Snapper CM
Interleukin 5 induces S mu-S gamma 1 DNA rearrangement in B cells activated with dextran-anti-IgD antibodies and interleukin 4: a three component model for Ig class switching.; The Journal of experimental medicine; Vol 178(5). 1993 Nov 01.
1. Chu CC
2. Max EE
3. Paul WE
DNA rearrangement can account for in vitro switching to IgG1.; The Journal of experimental medicine; Vol 178(4). 1993 Oct 01.
1. Chu CC
2. Paul WE
3. Max EE
Quantitation of immunoglobulin mu-gamma 1 heavy chain switch region recombination by a digestion-circularization polymerase chain reaction method.; Proceedings of the National Academy of Sciences of the United States of America; Vol 89(15). 1992 Aug 01.
1. Tanaka T
2. Chu CC
3. Paul WE
An antisense oligonucleotide complementary to a sequence in I gamma 2b increases gamma 2b germline transcripts, stimulates B cell DNA synthesis, and inhibits immunoglobulin secretion.; The Journal of experimental medicine; Vol 175(2). 1992 Feb 01.
1. Scappino LA
2. Chu C
3. Gritzmacher CA
Extended nucleotide sequence of the switch region of the murine gene encoding immunoglobulin E.; Gene; Vol 99(2). 1991 Mar 15.
1. Mahajan SK
2. Chu CC
3. Willis DK
4. Templin A
5. Clark AJ
Physical analysis of spontaneous and mutagen-induced mutants of Escherichia coli K-12 expressing DNA exonuclease VIII activity.; Genetics; Vol 125(2). 1990 Jun.
1. Chu CC
2. Clark AJ
A 10- rather than 9-bp duplication associated with insertion of Tn5 in Escherichia coli K-12.; Plasmid; Vol 22(3). 1989 Nov.
1. Chu CC
2. Templin A
3. Clark AJ
Suppression of a frameshift mutation in the recE gene of Escherichia coli K-12 occurs by gene fusion.; Journal of bacteriology; Vol 171(4). 1989 Apr.
1. Clark AJ
2. Sandler SJ
3. Willis DK
4. Chu CC
5. Blanar MA
6. Lovett ST
Genes of the RecE and RecF pathways of conjugational recombination in Escherichia coli.; Cold Spring Harbor symposia on quantitative biology; Vol 49. 1984.